Selected research
Industry Research
Gadobutrol Industry Research Report 2026
Market perspective
The global Gadobutrol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gadobutrol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gadobutrol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gadobutrol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gadobutrol include JinYan Chemicals (ShangHai), Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, MedKoo Biosciences, Manus Aktteva Biopharma, LGM Pharma, Jilin Tely Imp & Exp, BOC Sciences and Advanced Technology & Industrail, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gadobutrol market in terms of revenue (US$ million) and, where applicable, sales volume (m L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gadobutrol Market by Company
JinYan Chemicals (ShangHai)
Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
MedKoo Biosciences
Manus Aktteva Biopharma
LGM Pharma
Jilin Tely Imp & Exp
BOC Sciences
Advanced Technology & Industrail
Gadobutrol Segment by Type
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Gadobutrol Segment by Application
Adults
Children
Gadobutrol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadobutrol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadobutrol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadobutrol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gadobutrol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gadobutrol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gadobutrol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
- Pharmacy Bulk Packages (30 mL and 65 mL)
Applications
- Adults
- Children
Companies covered
- JinYan Chemicals (ShangHai)
- Bayer HealthCare Pharmaceuticals
- SWAPNROOP DRUGS & PHARMACEUTICALS
- MedKoo Biosciences
- Manus Aktteva Biopharma
- LGM Pharma
- Jilin Tely Imp & Exp
- BOC Sciences
- Advanced Technology & Industrail
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gadobutrol Market Size (2021-2032)
- 2.2.2 Global Gadobutrol Sales (2021-2032)
- 2.2.3 Global Gadobutrol Market Average Price (2021-2032)
- 2.3 Gadobutrol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
- 2.3.3 Pharmacy Bulk Packages (30 mL and 65 mL)
- 2.4 Gadobutrol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gadobutrol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gadobutrol Sales (m L) of Manufacturers (2021-2026)
- 3.3 Global Gadobutrol Revenue of Manufacturers (2021-2026)
- 3.4 Global Gadobutrol Average Price by Manufacturers (2021-2026)
- 3.5 Global Gadobutrol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gadobutrol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gadobutrol, Product Type & Application
- 3.8 Global Manufacturers of Gadobutrol, Established Date
- 3.9 Global Gadobutrol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 JinYan Chemicals (ShangHai)
- 4.1.1 JinYan Chemicals (ShangHai) Company Information
- 4.1.2 JinYan Chemicals (ShangHai) Business Overview
- 4.1.3 JinYan Chemicals (ShangHai) Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 JinYan Chemicals (ShangHai) Gadobutrol Product Portfolio
- 4.1.5 JinYan Chemicals (ShangHai) Recent Developments
- 4.2 Bayer HealthCare Pharmaceuticals
- 4.2.1 Bayer HealthCare Pharmaceuticals Company Information
- 4.2.2 Bayer HealthCare Pharmaceuticals Business Overview
- 4.2.3 Bayer HealthCare Pharmaceuticals Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer HealthCare Pharmaceuticals Gadobutrol Product Portfolio
- 4.2.5 Bayer HealthCare Pharmaceuticals Recent Developments
- 4.3 SWAPNROOP DRUGS & PHARMACEUTICALS
- 4.3.1 SWAPNROOP DRUGS & PHARMACEUTICALS Company Information
- 4.3.2 SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
- 4.3.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol Product Portfolio
- 4.3.5 SWAPNROOP DRUGS & PHARMACEUTICALS Recent Developments
- 4.4 MedKoo Biosciences
- 4.4.1 MedKoo Biosciences Company Information
- 4.4.2 MedKoo Biosciences Business Overview
- 4.4.3 MedKoo Biosciences Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 MedKoo Biosciences Gadobutrol Product Portfolio
- 4.4.5 MedKoo Biosciences Recent Developments
- 4.5 Manus Aktteva Biopharma
- 4.5.1 Manus Aktteva Biopharma Company Information
- 4.5.2 Manus Aktteva Biopharma Business Overview
- 4.5.3 Manus Aktteva Biopharma Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Manus Aktteva Biopharma Gadobutrol Product Portfolio
- 4.5.5 Manus Aktteva Biopharma Recent Developments
- 4.6 LGM Pharma
- 4.6.1 LGM Pharma Company Information
- 4.6.2 LGM Pharma Business Overview
- 4.6.3 LGM Pharma Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LGM Pharma Gadobutrol Product Portfolio
- 4.6.5 LGM Pharma Recent Developments
- 4.7 Jilin Tely Imp & Exp
- 4.7.1 Jilin Tely Imp & Exp Company Information
- 4.7.2 Jilin Tely Imp & Exp Business Overview
- 4.7.3 Jilin Tely Imp & Exp Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jilin Tely Imp & Exp Gadobutrol Product Portfolio
- 4.7.5 Jilin Tely Imp & Exp Recent Developments
- 4.8 BOC Sciences
- 4.8.1 BOC Sciences Company Information
- 4.8.2 BOC Sciences Business Overview
- 4.8.3 BOC Sciences Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BOC Sciences Gadobutrol Product Portfolio
- 4.8.5 BOC Sciences Recent Developments
- 4.9 Advanced Technology & Industrail
- 4.9.1 Advanced Technology & Industrail Company Information
- 4.9.2 Advanced Technology & Industrail Business Overview
- 4.9.3 Advanced Technology & Industrail Gadobutrol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Advanced Technology & Industrail Gadobutrol Product Portfolio
- 4.9.5 Advanced Technology & Industrail Recent Developments
5 Global Gadobutrol Market Scenario by Region
- 5.1 Global Gadobutrol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gadobutrol Sales by Region: 2021-2032
- 5.2.1 Global Gadobutrol Sales by Region: 2021-2026
- 5.2.2 Global Gadobutrol Sales by Region: 2027-2032
- 5.3 Global Gadobutrol Revenue by Region: 2021-2032
- 5.3.1 Global Gadobutrol Revenue by Region: 2021-2026
- 5.3.2 Global Gadobutrol Revenue by Region: 2027-2032
- 5.4 North America Gadobutrol Market Facts & Figures by Country
- 5.4.1 North America Gadobutrol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gadobutrol Sales by Country (2021-2032)
- 5.4.3 North America Gadobutrol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Gadobutrol Market Facts & Figures by Country
- 5.5.1 Europe Gadobutrol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gadobutrol Sales by Country (2021-2032)
- 5.5.3 Europe Gadobutrol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Gadobutrol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gadobutrol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gadobutrol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gadobutrol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gadobutrol Market Facts & Figures by Country
- 5.7.1 South America Gadobutrol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gadobutrol Sales by Country (2021-2032)
- 5.7.3 South America Gadobutrol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Gadobutrol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gadobutrol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gadobutrol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gadobutrol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Gadobutrol Sales by Type (2021-2032)
- 6.1.1 Global Gadobutrol Sales by Type (2021-2032) & (m L)
- 6.1.2 Global Gadobutrol Sales Market Share by Type (2021-2032)
- 6.2 Global Gadobutrol Revenue by Type (2021-2032)
- 6.2.1 Global Gadobutrol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gadobutrol Revenue Market Share by Type (2021-2032)
- 6.3 Global Gadobutrol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gadobutrol Sales by Application (2021-2032)
- 7.1.1 Global Gadobutrol Sales by Application (2021-2032) & (m L)
- 7.1.2 Global Gadobutrol Sales Market Share by Application (2021-2032)
- 7.2 Global Gadobutrol Revenue by Application (2021-2032)
- 7.2.1 Global Gadobutrol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gadobutrol Revenue Market Share by Application (2021-2032)
- 7.3 Global Gadobutrol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gadobutrol Value Chain Analysis
- 8.1.1 Gadobutrol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gadobutrol Production Mode & Process
- 8.2 Gadobutrol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gadobutrol Distributors
- 8.2.3 Gadobutrol Customers
9 Global Gadobutrol Analyzing Market Dynamics
- 9.1 Gadobutrol Industry Trends
- 9.2 Gadobutrol Industry Drivers
- 9.3 Gadobutrol Industry Opportunities and Challenges
- 9.4 Gadobutrol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst